Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Interim Report for the period April – June 2023

LEQEMBI® approved in the US – the world’s first fully approved disease-modifying treatment for Alzheimer’s disease  Events during the second quarter 2023 · The U.S. Food and Drug Administration’s (FDA) Advisory Committee voted unanimously that the data from BioArctic’s partner Eisai’s Phase 3 Clarity AD clinical trial confirms the clinical benefit of LEQEMBI® (US brand name for lecanemab) · Eisai submitted applications for marketing authorization for lecanemab in South Korea and Great Britain · Health Canada initiated the review of New Drug Submission for lecanemab as

Konecranes’ January-June 2023 half-year financial report will be published on July 26, 2023

KONECRANES PLC PRESS RELEASE July 12, 2023 at 09:00 AM EEST   Konecranes’ January-June 2023 half-year financial report will be published on July 26, 2023   Konecranes will publish its January-June 2023 half-year financial report on Wednesday, July 26, 2023 at approximately 8:30 a.m. EEST. The report will be available on the company’s website at www.konecranes.com after publishing.   A live international webcast and telephone conference for analysts, investors and media will be arranged on the publishing day at 11:30 a.m. EEST. The event will be held in English. The half-

Remedy Entertainment Plc: Publishing time for Half-Year Financial Report 2023

Remedy Entertainment Plc | Press Release July 12, 2023, 09:00 a.m. (EEST) Publishing time for Half-Year Financial Report 2023 Remedy Entertainment Plc will publish its Half-Year Financial Report 2023 on Friday August 11, 2023, at 9:00 a.m. (EEST). Remedy will host a webcast and conference call in English on its financial results for investors, analysts and media on Friday August 11, 2023, at 2:00 p.m. (EEST). Remedy’s financial results will be presented by CEO Tero Virtala and CFO Terhi Kauppi. The half-year report will be available after publication on Remedy’s Investor

Proact demonstrates commitment to information security excellence with ISO 27001 certification in Estonia

Proact, Europe’s leading independent data centre and cloud services provider, has successfully obtained the ISO 27001:2013 certification, a globally recognised standard for information security management systems (ISMS). Such an achievement demonstrates the company's commitment to storing and protecting sensitive information.In Estonia Proact provides infrastructure management, software management as well as private, hybrid and public cloud services. Regardless of service, this certificate reassures the company’s customers and partners that the organisation has enacted strict security

Peab builds elementary school in Höllviken

Peab has been commissioned to build a new elementary school in Höllviken in Vellinge Municipality. The customer is Vellinge Municipality and the contract is worth SEK 281 million.The new Henriksdal School will be a K-9 school with a GFA of 12,300 m2. The school will include a commercial kitchen, a cafeteria and music, home economics and art classrooms as well as a gym for 550 students. The school will be built in architecture typical for Skåne with facades of brick, wood and sheet metal. The building will also meet the requirements and be able to be certified for Miljöbyggnad, level

Sedana Medical informs about adjusted US submission plan following FDA interaction

Sedana Medical AB (publ) today informs that the US Food and Drug Administration (FDA) has requested the company to include long-term outcomes data in the Clinical Study Report (CSR) of the INSPIRE-ICU trials before the New Drug Application (NDA) can be submitted. This is expected to move the filing date by approximately one year to Q1 2025, but is not expected to materially impact the overall cost for the clinical program.INSPIRE-ICU 1&2 are two identical phase III studies to confirm the efficacy and safety of inhaled isoflurane delivered via Sedaconda ACD, compared to IV propofol, for

Fremtind Forsikring - Result 2nd quarter and year to date

SpareBank 1 SR-Bank has an ownership interest of 19,5 % in SpareBank 1 Gruppen AS. Fremtind is 65% owned by SpareBank 1 Gruppen AS. Fremtind's profit before tax as at 30 June 2023 was NOK 346 (706*) million and NOK 280 (525*) million after tax. Isolated for the 2nd quarter, Fremtind's result was -19 (310*) before tax and 7 (233*) million NOK after tax. SpareBank 1 SR-Bank share of Fremtind's profit before tax per 30 June was 44 (89*) million NOK. *Figures in bracket indicate restated figures according to IFRS 17/IFRS 19 for the corresponding period in 2022. Stavanger, 12 July 2023

Growth and strong results in a robust Norwegian economy

DNB’s profit in the second quarter of 2023 was NOK 9 462 million. This is an increase of NOK 1 505 million, or 18.9 per cent, from the corresponding quarter of 2022. “We’re growing in both the personal and corporate customer markets, and we’re pleased that many new customers are choosing us,” says Kjerstin Braathen, Group Chief Executive Officer (CEO) of DNB. Behind the strong results lies a robust Norwegian economy, even though the level of activity in the economy has slowed somewhat during the spring, and general uncertainty has risen. Unemployment remains at a very low level and is

BlueNord Announce Second Quarter 2023 Results

Oslo, 12 July 2023: BlueNord ASA ("BlueNord" or the "Company") today published its second quarter and first half year 2023 results. The second quarter of the year delivered excellent operational performance which supported the overall financial performance of the Company. Highlights:•    Second quarter net hydrocarbon production of 23.6 mboepd, above quarterly guidance of 22.5 - 23.5•    Revenues of USD 191 million for the quarter and USD 411 million for first half of 2023•    EBITDA in Q2 of USD 99 million, delivering EBITDA for H1 of USD 220 million•    Operating Cash Flow in

ShaMaran Operational and Corporate Update

VANCOUVER, BC, July 12, 2023 /CNW/ – ShaMaran Petroleum Corp. (TSX Venture and Nasdaq First North: SNM) (“ShaMaran” or the “Company”) announces an operational and corporate update.  The Company’s operations remain heavily impacted by the continued closure of the Iraq-Turkey pipeline (“ITP”), which has resulted in either a partial or complete shutdown of many fields located in the Kurdistan region of Iraq (“KRI”). ShaMaran understands that negotiations between officials in Iraq and Turkey about re-opening the ITP started in late June and will continue in the weeks ahead. The recent

Heatcube´s high voltage connection to grid at Nordjylland Power Station successfully commissioned

Oslo, Norway 12 July 2023 - Kyoto Group is pleased to announce that the first ever full-scale Heatcube, at the Nordjylland Power Station in Aalborg, Denmark (“Norbis Park”) has now been connected to the grid and the high voltage connection between the transformer building and the world’s largest electrical heater for molten salt, as a key equipment of Heatcube, has been successfully commissioned.The connection and electronical testing of the heater were accompanied by a team of technicians from Vulcanic, the Spirax Sarco company that has delivered the electrical heater to Heatcube at Norbis

Capsol Technologies gains traction in carbon capture from Cement – Awarded feasibility study for large cement plant

Oslo, Norway – 12 July 2023Capsol Technologies has been awarded a feasibility study for the CapsolEoP®(end-of-pipe) carbon capture technology at a cement plant in Northern Europe.The study is for a plant aiming to capture more than 1 million tonnes of CO2 perannum – a significant amount and a significant impact. The award is CapsolTechnologies first paid engineering study on a cement plan. The company isseeing an increasing amount of request and sales engineering work in the cementsector, expecting more engineering studies to be awarded going forward.“The cement industry is

As the growth of streaming slows, service providers need to exploit their opportunities wisely

Ahead of Netflix’s announcement of its second quarter financial results later this month, Simon-Kucher’s latest study shows that Australian streamers are doubling down on price being the most important purchase criterion, followed by breadth of content available. · Only 36 percent of respondents in Australia indicate they stream more compared to last year, a decline of 13 percentage points as compared to the 2022 study · The gap between free online services and paid subscription services is starting to close, with free online services accounting for 33 percent of total streaming time (

Latest data on lecanemab to be presented at Alzheimer’s Association International Conference (AAIC) 2023

Stockholm, July 12, 2023 – BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai will present the latest findings on lecanemab, an anti-amyloid beta (Aβ) protofibril antibody for the treatment of Alzheimer’s disease, at the Alzheimer’s Association International Conference (AAIC). The conference will be held in Amsterdam, the Netherlands and virtually from July 16 to 20, 2023.Key Eisai lecanemab AAIC presentations · Amyloid Reduction and Evidence of Downstream Biomarker ModificationPresentation of results of Aβ, tau, neurodegeneration, gliosis, and imaging biomarkers in the

Filo Extends Aurora 260m Northeast with 1,131m at 0.57% CuEq; Expands Bonita 700m East with 879m at 0.47% CuEq

VANCOUVER, BC, JULY 11, 2023 /CNW/ - Filo Corp. (TSX: FIL) (Nasdaq First North Growth Market: FIL) (OTCQX: FLMMF) (“Filo”, or the “Company”) announces assay results from three holes testing extensions to the Aurora and Bonita Zones and the Gemelos target at the Filo del Sol Project in San Juan, Argentina. Highlights and detailed results are shown below along with accompanying figures: · Drillhole FSDH083 extends the Filo-Aurora trend 260m to the northeast with 1,131m at 0.57% CuEq from 419m including: · 112m at 0.70% CuEq from 560m · 210m at 0.80% CuEq from 970m   ·

Immunovia to Significantly Restructure to Focus Resources on its Next-Generation Blood Test for Pancreatic Cancer Detection

LUND (SWEDEN) – LUND (SWEDEN) – Immunovia (Nasdaq Stockholm: IMMNOV), the diagnostics company focused on early detection of pancreatic cancer, today announced plans to restructure its operations. The company will cease commercialization of its IMMray PanCan-d test in the United States to focus its resources on the further development and clinical testing of the Company’s promising next generation pancreatic cancer detection test.   The next generation assay currently in development is intended to work equally well across multiple patient risk groups. The new test is expected to

ABS Issues AIP for New Ammonia-Fueled Containership

(SEOUL) ABS awarded an approval in principle (AIP) to Korea Maritime Consultants Co., Ltd. (KOMAC) for an innovative design of an ammonia-fueled containership.   The 3,600-TEU vessel is a design from KOMAC to address what they forecast as an increase in market need for small-scale, ammonia-fueled vessels. Given the challenging characteristics of ammonia, ABS conducted a comprehensive review and participated in the risk assessment of the ammonia fuel system in the AIP process to address safety and reliability. “Ammonia offers both significant potential to contribute to

Kongsberg Automotive completes the share purchase in Chassis Autonomy, expanding its autonomous driving product portfolio

Zurich, July 11, 2023: Kongsberg Automotive AS (KA) has signed an agreement to acquire 20% of the shares in Chassis Autonomy SBA AB  (Chassis Autonomy) via a directed rights issue. The agreement further includes call options to acquire up to 100% of the total outstanding shares within 2027. Additionally, KA has entered an exclusive partnership collaboration with Chassis Autonomy to support the continued growth of the company and unlock its market potential. Chassis Autonomy specializes in the design and development of steer-by-wire and brake-by-wire

Noble Corporation plc announces the initiation of a quarterly dividend

SUGAR LAND, TEXAS, July 11, 2023 /CNW/ - Noble Corporation plc ("Noble" or the “Company”) (CSE: NOBLE, NYSE: NE) today announces that the board of directors has declared a quarterly interim dividend on its A ordinary shares (“shares”) of $0.30 per share.  This dividend is to be payable on September 14, 2023, to shareholders of record at close of business on August 17, 2023. Going forward, the Company intends to pay dividends on a quarterly basis, and this initial dividend represents $1.20 on an annualized basis. President and Chief Executive Officer Robert W. Eifler commented: “We are

Nordea Bank Abp: Repurchase of own shares on 11.07.2023

Nordea Bank AbpStock exchange release – Changes in company’s own shares11.07.2023 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 11.07.2023 completed repurchases of own shares (ISIN: FI4000297767) as follows: +----------+-------+-------------------+-------------------+| Trading |Number | Weighted average |Total cost, EUR* **||venue (MIC| of |price / share, EUR*| || Code) |shares | ** | |+----------+-------+-------------------+-------------------+|XHEL |90,626 |9.77 |885,243.83

Pharmacolog announces outcome in rights issue

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION WHERE RELEASE, DISTRIBUTION OR PUBLICATIONOF THIS PRESS RELEASE WOULD BE UNLAWFULOR WOULD REQUIRE FURTHER REGISTRATION OR ANY OTHER MEASURES. Pharmacolog i Uppsala AB (publ) ("Pharmacolog" or the "Company") has completed the rights issue of units, consisting of shares and warrants of series TO3, which the board of directors

SmartCraft ASA (SMCRT) - Transactions carried out under the share buy-back program

Please see below information about transactions made under the share buy-back programme for SmartCraft ASA (“SmartCraft”) (Ticker: SMCRT NO). Date on which the share buy-back programme was announced: 28 April 2023. The duration of the buy-back programme: 28 April 2023 until no later than the day before the Issuer's Annual General Meeting in 2024. Size of the buy-back programme: Up to 3,430,446 shares, for a maximum consideration of NOK 85,000,000. From 01 July 2023 until 11 July 2023, SmartCraft has purchased a total of 147,743 own shares at an average price of NOK 21.6895 per

Transaction in Own Shares

FIDELITY CHINA SPECIAL SITUATIONS PLC TRANSACTION IN OWN SHARES The Board of Fidelity China Special Situations Plc ("the Company") announces that on 11 July 2023 the Company bought 130,000 of its own shares for cancellation at a price of 205.289 pence per share.  The Company's issued ordinary share capital is 567,109,501 shares of which 85,629,548 shares are held in Treasury, which attract no voting rights. Therefore, the total number of voting rights in the Company is 481,479,953. The above figure (481,479,953) may be used by shareholders as the denominator for the

How to Make Your Garden Look Glam on a Budget

Are you looking for some great budget-friendly ideas on how to make your garden look glam on a budget? It’s easier and cheaper than you may think to give your garden a decent makeover, and gardening expert Fiona Jenkins at MyJobQuote.co.uk  has all the tips you need to improve your garden’s appearance without breaking the bank.   [A garden fork and a watering can in the dirt Description automatically generated]   Whether it’s fixing up your lawn or getting creative with lights, take a look at the list below to find out how to make your garden look

There are no items matching the current filter
There are no more items matching the current filter
Back to top